• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于定义埃德蒙顿症状评估系统中度和重度症状的单一数值切点。

A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System.

机构信息

Palliative Care Department, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario M4N 3M5, Canada.

出版信息

J Pain Symptom Manage. 2010 Feb;39(2):241-9. doi: 10.1016/j.jpainsymman.2009.06.010. Epub 2009 Dec 5.

DOI:10.1016/j.jpainsymman.2009.06.010
PMID:19963335
Abstract

Symptom intensity in cancer and palliative care patients is frequently assessed using a 0-10 ranking score. Results are then often grouped into verbal categories (mild, moderate, or severe) to guide therapy. Numerical cutpoints separating these categories are often variable, with previous work suggesting different cutpoints across different symptoms, which is unwieldy for clinical use. The Edmonton Symptom Assessment Symptom (ESAS) assesses nine common symptoms using this 0-10 scale. The primary aim of this study was to examine the relationship between the numerical and verbal scores using the ESAS and to identify a single cutpoint to separate severe from nonsevere symptomatology. A second goal was to similarly identify a cutpoint to separate moderate or severe from none or mild symptom intensity. Consenting patients (n=400) completed both a standard ESAS and an identical form that replaced 0-10 with none, mild, moderate, and severe. Receiver operating characteristic curves were generated to identify the best fit between sensitivity and specificity. For the "severe" ranking, six symptoms had a best fit of 7, with sensitivity for the remaining three symptoms still greater than 80%. For the combined grouping of moderate or severe, results were less uniform. A cutpoint of either 4 or 5 would be supported by our data, with a greater sensitivity using 4 and improved specificity using 5 as the cutpoint. Across all ESAS symptoms, then, 7 or higher represents a severe symptom by patient definition, whereas a cutpoint of either 4 or 5 could reasonably define combined moderate and severe symptoms.

摘要

在癌症和姑息治疗患者中,症状强度通常使用 0-10 分的评分进行评估。结果通常分为口头类别(轻度、中度或重度)以指导治疗。区分这些类别的数值切点通常是可变的,之前的工作表明不同的症状有不同的切点,这对于临床使用来说很不方便。埃德蒙顿症状评估量表(ESAS)使用这种 0-10 量表评估九种常见症状。这项研究的主要目的是检查 ESAS 中数字评分和口头评分之间的关系,并确定一个单一的切点来区分严重和非严重的症状表现。第二个目标是同样确定一个切点来区分中度或重度与无或轻度症状强度。同意参与的患者(n=400)完成了标准 ESAS 量表和一份完全相同的量表,其中用无、轻度、中度和重度替代了 0-10 分。生成了接收者操作特征曲线来确定灵敏度和特异性之间的最佳拟合。对于“严重”等级,有六个症状的最佳拟合值为 7,其余三个症状的灵敏度仍大于 80%。对于中度或重度的综合分组,结果则不那么一致。我们的数据支持 4 或 5 作为切点,使用 4 作为切点灵敏度更高,使用 5 作为切点特异性更好。那么,在所有 ESAS 症状中,7 或更高表示患者定义的严重症状,而 4 或 5 的切点可以合理地定义中度和重度的综合症状。

相似文献

1
A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System.用于定义埃德蒙顿症状评估系统中度和重度症状的单一数值切点。
J Pain Symptom Manage. 2010 Feb;39(2):241-9. doi: 10.1016/j.jpainsymman.2009.06.010. Epub 2009 Dec 5.
2
Impact of palliative care unit admission on symptom control evaluated by the edmonton symptom assessment system.通过埃德蒙顿症状评估系统评估姑息治疗病房入院对症状控制的影响。
J Pain Symptom Manage. 2005 Oct;30(4):367-73. doi: 10.1016/j.jpainsymman.2005.04.007.
3
Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.使用埃德蒙顿症状评估系统修订版日语版确定定义症状严重程度的临界值。
J Pain Symptom Manage. 2016 Feb;51(2):292-7. doi: 10.1016/j.jpainsymman.2015.09.011. Epub 2015 Oct 24.
4
Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan.姑息性镇静治疗的疗效与安全性:一项在日本专科姑息治疗病房开展的多中心、前瞻性观察性研究。
J Pain Symptom Manage. 2005 Oct;30(4):320-8. doi: 10.1016/j.jpainsymman.2005.03.017.
5
A longitudinal study of palliative care: patient-evaluated outcome and impact of attrition.姑息治疗的纵向研究:患者评估结果及失访影响
Cancer. 2005 Apr 15;103(8):1747-55. doi: 10.1002/cncr.20958.
6
Symptom distress in patients attending an outpatient palliative radiotherapy clinic.门诊姑息性放疗诊所患者的症状困扰
J Pain Symptom Manage. 2005 Aug;30(2):123-31. doi: 10.1016/j.jpainsymman.2005.02.015.
7
A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients.一项多中心研究比较了两种数字版埃德蒙顿症状评估系统在姑息治疗患者中的应用。
J Pain Symptom Manage. 2011 Feb;41(2):456-68. doi: 10.1016/j.jpainsymman.2010.04.020. Epub 2010 Sep 15.
8
Phase II study of an outpatient palliative care intervention in patients with metastatic cancer.转移性癌症患者门诊姑息治疗干预的II期研究。
J Clin Oncol. 2009 Jan 10;27(2):206-13. doi: 10.1200/JCO.2008.17.7568. Epub 2008 Dec 8.
9
Symptom priority and course of symptomatology in specialized palliative care.专科姑息治疗中的症状优先级及症状学进程
J Pain Symptom Manage. 2006 Mar;31(3):199-206. doi: 10.1016/j.jpainsymman.2005.07.007.
10
Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology.转诊至姑息治疗的癌症患者的自我评估:可行性与症状流行病学研究
Cancer. 2002 Jan 15;94(2):512-20. doi: 10.1002/cncr.10222.

引用本文的文献

1
Patient-Reported Symptoms and Mental Health Event Risks in Adolescents and Young Adults With Cancer.癌症青少年和青年患者报告的症状及心理健康事件风险
Cancer Med. 2025 Aug;14(15):e71096. doi: 10.1002/cam4.71096.
2
A scenario-driven simulation approach to sustainable hospital resource management: aging society, pandemic preparedness and referral enhancement.一种基于情景驱动模拟的可持续医院资源管理方法:应对老龄化社会、大流行防范及转诊优化。
BMC Health Serv Res. 2025 Jul 27;25(1):982. doi: 10.1186/s12913-025-13221-7.
3
Intellectual and Developmental Disabilities and Cancer Symptom Severity: A Matched Retrospective Cohort Study.
智力与发育障碍和癌症症状严重程度:一项匹配的回顾性队列研究。
Psychooncology. 2025 Jun;34(6):e70199. doi: 10.1002/pon.70199.
4
Emergency palliative cancer care: anxiety and midazolam.癌症紧急姑息治疗:焦虑与咪达唑仑
BMC Palliat Care. 2025 Mar 13;24(1):64. doi: 10.1186/s12904-025-01687-5.
5
A Prognostic Symptom Model Incorporating Patient-Reported Symptoms for Transplant-Ineligible Patients with Multiple Myeloma.一种纳入患者报告症状的预后症状模型,用于不适宜移植的多发性骨髓瘤患者。
Cancers (Basel). 2025 Feb 1;17(3):489. doi: 10.3390/cancers17030489.
6
Using journey maps to understand patientreported outcome measures in the cancer journey.使用旅程地图来理解癌症诊疗过程中患者报告的结局指标。
Can Oncol Nurs J. 2024 Nov 1;34(4):443-476. doi: 10.5737/23688076344443. eCollection 2024 Fall.
7
Patient-Reported Outcome Measures in Patients with and without Non-Expandable Lung Secondary to Malignant Pleural Effusion-A Single-Centre Observational Study.恶性胸腔积液导致的不可扩张肺患者与无此情况患者的患者报告结局指标——一项单中心观察性研究
Diagnostics (Basel). 2024 Jun 3;14(11):1176. doi: 10.3390/diagnostics14111176.
8
Undergoing Lung Surgery (PSA-Lung) was appropriate for symptom assessment after discharge.接受肺手术(PSA-Lung)适合出院后进行症状评估。
Qual Life Res. 2024 Jul;33(7):1807-1818. doi: 10.1007/s11136-024-03636-w. Epub 2024 May 12.
9
A novel psychosocial virtual reality intervention (BMT-VR) for patients undergoing hematopoietic stem cell transplantation: Pilot randomized clinical trial design and methods.一种新型的针对接受造血干细胞移植患者的心理社会虚拟现实干预(BMT-VR): 基于患者报告结局的随机临床试验设计与方法。
Contemp Clin Trials. 2024 Jul;142:107550. doi: 10.1016/j.cct.2024.107550. Epub 2024 Apr 27.
10
SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer.SMART-ESAS:用于癌症患者的 Edmonton 症状评估系统评分的实时智能手机监测和评估。
JCO Glob Oncol. 2024 Feb;10:e2300447. doi: 10.1200/GO.23.00447.